ClinicalTrials.Veeva

Menu

The Relationship Between Peripheral Arterial Disease and Mitochondrial Respiratory Capacity

N

Norwegian University of Science and Technology

Status

Completed

Conditions

Intermittent Claudication

Study type

Observational

Funder types

Other

Identifiers

NCT02434783
2015/204

Details and patient eligibility

About

Current evidence cannot explain the clinical features of peripheral arterial disease only from the principle of reduced blood flow. Explanations have therefore in addition been linked to mitochondrial dysfunction of skeletal muscles.

This study will elucidate whether there is a relation between clinical variables of the different levels of arterial insufficiency in peripheral arterial disease and mitochondrial respiratory capacity.

Enrollment

16 patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Asymptotic peripheral arterial disease (Ankle-brachial index < 0.9), intermittent claudication (Ankle-brachial index 0.4 - 0.9), or critical limb ischemia (Ankle-brachial index < 0.4)

Exclusion criteria

  • Diagnosed with intermittent claudication secondary to vascular insufficiency
  • Warfarin or heparin usage
  • Underwent a vascular intervention in the last 6 months
  • Active cancer, renal- or liver disease

Trial design

16 participants in 4 patient groups

1st level of arterial insufficiency
Description:
asymptomatic PAD patients
2nd level of arterial insufficiency
Description:
Intermittent claudication patients
3rd level of arterial insufficiency
Description:
Critical limb ischemia patients
No arterial insufficiency
Description:
Healthy individuals (control)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems